Showing results (71-80 of 110) with videos related to

Sort By:
Pageof 11
Journal of Experimental & Clinical Cancer Research : CR|November 11, 2024
Drug prioritization identifies panobinostat as a tailored treatment element for patients with metastatic hepatoblastomaSalih Demir, Alina Hotes, Tanja Schmid, et al.
European Journal of Cancer (Oxford, England : 1990)|October 30, 2020
A combined clinical and biological risk classification improves prediction of outcome in hepatoblastoma patientsStefano Cairo, Carolina Armengol, Rudolf Maibach, et al.
Blood|October 23, 2020
CLEC12A and CD33 coexpression as a preferential target for pediatric AML combinatorial immunotherapySemjon Willier, Paula Rothämel, Maximilian Hastreiter, et al.
Haematologica|August 5, 2021
Clofarabine increases the eradication of minimal residual disease of primary B-precursor acute lymphoblastic leukemia compared to high-dose cytarabine without improvement of outcome. Results from the randomized clinical trial 08-09 of the Cooperative Acute Lymphoblastic Leukemia Study GroupGabriele Escherich, Udo Zur Stadt, Arndt Borkhardt, et al.
Cancers|September 9, 2022
Targeting the Unwindosome by Mebendazole Is a Vulnerability of Chemoresistant HepatoblastomaQian Li, Salih Demir, Álvaro Del Río-Álvarez, et al.
The Journal of Pediatrics|May 7, 2014
Hemophagocytic lymphohistiocytosis in imported pediatric visceral leishmaniasis in a nonendemic areaSebastian F N Bode, Christian Bogdan, Karin Beutel, et al.
Pediatric Blood & Cancer|September 17, 2011
Sorafenib and cisplatin/doxorubicin (PLADO) in pediatric hepatocellular carcinomaIrene Schmid, Beate Häberle, Michael H Albert, et al.
Cancers|February 25, 2022
Long-Term Clinical Outcome and Prognostic Factors of Children and Adolescents with Localized Rhabdomyosarcoma Treated on the CWS-2002P ProtocolEwa Koscielniak, Bernd Blank, Christian Vokuhl, et al.
Pediatric Blood & Cancer|January 24, 2017
First experience of the AML-Berlin-Frankfurt-Münster group in pediatric patients with standard-risk acute promyelocytic leukemia treated with arsenic trioxide and all-trans retinoid acidUrsula Creutzig, Michael N Dworzak, Konrad Bochennek, et al.
Pediatric Blood & Cancer|March 3, 2024
Efficacy and safety of azacitidine in pediatric patients with newly diagnosed advanced myelodysplastic syndromes before hematopoietic stem cell transplantation in the AZA-JMML-001 trialFranco Locatelli, Karin Belander Strålin, Irene Schmid, et al.
Pageof 11